150 related articles for article (PubMed ID: 12812134)
21. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Qua CS; Wong CH; Gopala K; Goh KL
Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
[TBL] [Abstract][Full Text] [Related]
22. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
24. Review article: alternative approaches to the long-term management of GERD.
Fennerty MB
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
[TBL] [Abstract][Full Text] [Related]
25. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
26. Relationship between symptom response and oesophageal acid exposure after medical and surgical treatment for gastro-oesophageal reflux disease.
Jenkinson AD; Kadirkamanathan SS; Scott SM; Yazaki E; Evans DF
Br J Surg; 2004 Nov; 91(11):1460-5. PubMed ID: 15386326
[TBL] [Abstract][Full Text] [Related]
27. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
[TBL] [Abstract][Full Text] [Related]
28. Dysphonia and laryngopharyngeal reflux.
Cesari U; Galli J; Ricciardiello F; Cavaliere M; Galli V
Acta Otorhinolaryngol Ital; 2004 Feb; 24(1):13-9. PubMed ID: 15270428
[TBL] [Abstract][Full Text] [Related]
29. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
30. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Todd JA; Basu KK; de Caestecker JS
Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
[TBL] [Abstract][Full Text] [Related]
31. Non-linear associations between laryngo-pharyngeal symptoms of gastro-oesophageal reflux disease: clues from artificial intelligence analysis.
Grossi E
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):293-8. PubMed ID: 17345935
[TBL] [Abstract][Full Text] [Related]
32. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
[TBL] [Abstract][Full Text] [Related]
33. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
Kiljander T; Salomaa ER; Hietanen E; Helenius H; Liippo K; Terho EO
Respir Med; 2001 May; 95(5):387-92. PubMed ID: 11392580
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.
Raghu G; Freudenberger TD; Yang S; Curtis JR; Spada C; Hayes J; Sillery JK; Pope CE; Pellegrini CA
Eur Respir J; 2006 Jan; 27(1):136-42. PubMed ID: 16387946
[TBL] [Abstract][Full Text] [Related]
35. Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).
Maceri DR; Zim S
Laryngoscope; 2001 Nov; 111(11 Pt 1):1976-9. PubMed ID: 11801981
[TBL] [Abstract][Full Text] [Related]
36. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
[TBL] [Abstract][Full Text] [Related]
37. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
38. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
[TBL] [Abstract][Full Text] [Related]
39. Globus sensation and gastroesophageal reflux.
Chevalier JM; Brossard E; Monnier P
Eur Arch Otorhinolaryngol; 2003 May; 260(5):273-6. PubMed ID: 12750918
[TBL] [Abstract][Full Text] [Related]
40. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
Hillman AL; Bloom BS; Fendrick AM; Schwartz JS
Arch Intern Med; 1992 Jul; 152(7):1467-72. PubMed ID: 1627026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
